• 1. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to Methyl (2S,3R)-2-amino-3-(tert-butoxy)butanoate (CAS No. 24205-25-2)

Methyl (2S,3R)-2-amino-3-(tert-butoxy)butanoate, a compound with the chemical formula C₈H₁₇O₃N, is a significant molecule in the field of pharmaceutical chemistry and biochemistry. This compound is characterized by its (2S,3R) stereochemistry, which plays a crucial role in its biological activity and interaction with biological targets. The presence of a tert-butoxy group at the third carbon position enhances its stability and solubility, making it a valuable intermediate in the synthesis of more complex molecules.

The CAS number 24205-25-2 uniquely identifies this compound in scientific literature and databases, facilitating accurate referencing and research. Methyl (2S,3R)-2-amino-3-(tert-butoxy)butanoate has garnered attention due to its potential applications in drug development and as a building block for more sophisticated pharmacophores. Its structural features make it an attractive candidate for further investigation in medicinal chemistry.

In recent years, there has been growing interest in chiral compounds due to their selective interactions with biological systems. The (2S,3R) configuration of this molecule is particularly noteworthy, as it influences its enantioselective properties. Research has shown that such stereochemical arrangements can significantly impact the efficacy and safety of therapeutic agents. The tert-butoxy group not only contributes to the compound's stability but also modulates its pharmacokinetic profile, making it a promising candidate for further development.

One of the most compelling aspects of Methyl (2S,3R)-2-amino-3-(tert-butoxy)butanoate is its potential role in the synthesis of novel drugs. Its structural motif is reminiscent of amino acid derivatives, which are fundamental in many biological processes. The combination of an amino group and a hydroxyl group at specific positions allows for diverse chemical modifications, enabling the creation of molecules with tailored biological activities. This flexibility makes it an invaluable tool for medicinal chemists.

Recent studies have explored the use of Methyl (2S,3R)-2-amino-3-(tert-butoxy)butanoate as a precursor in the synthesis of enzyme inhibitors. Enzyme inhibition is a key strategy in drug design, as many therapeutic agents work by binding to and inhibiting specific enzymes involved in disease pathways. The stereochemistry and functional groups present in this compound make it an excellent candidate for developing such inhibitors. For instance, researchers have investigated its potential as an inhibitor of peptidases, which are enzymes implicated in various diseases including cancer and inflammation.

The tert-butoxy group has been particularly studied for its ability to enhance binding affinity and selectivity. This group can sterically hinder unwanted interactions while maintaining strong binding to the target site. Such properties are critical for developing drugs that exhibit high efficacy with minimal side effects. The amino group at the second carbon position also provides opportunities for further functionalization, allowing chemists to explore a wide range of possible derivatives.

In addition to its role in drug development, Methyl (2S,3R)-2-amino-3-(tert-butoxy)butanoate has been utilized in biochemical research as a substrate or intermediate. Its structural similarity to natural amino acids makes it a useful tool for studying enzymatic reactions and metabolic pathways. By incorporating this compound into experimental systems, researchers can gain insights into how enzymes recognize and process substrates, which is essential for understanding both normal physiological processes and disease mechanisms.

The synthesis of Methyl (2S,3R)-2-amino-3-(tert-butoxy)butanoate involves multi-step organic reactions that require precise control over reaction conditions and stereochemistry. Advances in synthetic methodologies have made it increasingly feasible to produce enantiomerically pure forms of such compounds. This has opened up new avenues for research, particularly in the development of enantiopure drugs that offer improved therapeutic profiles.

One area where this compound has shown promise is in the field of protease inhibition. Proteases are enzymes that play crucial roles in various biological processes, including protein degradation and signal transduction. Inhibiting specific proteases has been effective in treating conditions such as arthritis and cancer. The unique structural features of Methyl (2S,3R)-2-amino-3-(tert-butoxy)butanoate make it an attractive scaffold for designing protease inhibitors with high specificity and potency.

The (2S,3R) stereochemistry is particularly important in this context, as it allows the compound to mimic natural substrates recognized by proteases. By binding to the active site of these enzymes, Methyl (2S,3R)-2-amino-3-(tert-butoxy)butanoate or its derivatives can inhibit their activity without affecting other enzymes. This selectivity is crucial for developing drugs that are effective yet have minimal side effects.

Another exciting application of Methyl (2S,3R)-2-amino-3-(tert-butoxy)butanoate is in the development of chiral catalysts. Chiral catalysts are used to facilitate enantioselective reactions, allowing chemists to produce enantiomerically pure compounds efficiently. The presence of chiral centers in this molecule makes it a potential candidate for designing such catalysts. By developing effective chiral catalysts based on this scaffold, researchers can streamline synthetic routes and improve access to important pharmaceutical intermediates.

The growing interest in green chemistry has also influenced research on Methyl (2S,3R)-2-amino-3-(tert-butoxy)butanoate. Green chemistry principles emphasize sustainable practices that minimize waste and environmental impact. Researchers have been exploring synthetic routes that use renewable feedstocks and energy-efficient methods to produce this compound. These efforts align with broader goals in pharmaceutical manufacturing to develop processes that are both efficient and environmentally friendly.

In conclusion, Methyl (2S,3R)-2-amino-3-(tert-butoxy)butanoate is a versatile and promising compound with significant applications in pharmaceutical chemistry and biochemistry. Its unique structural features make it an excellent candidate for drug development as well as a valuable tool for biochemical research. As our understanding of biological systems continues to grow, compounds like Methyl (2S,3R)-2-amino-3-(tert-butoxy)butanoate will undoubtedly play an increasingly important role in advancing medical science.

• 201353-89-1(H-Allo-thr(tbu)-OH)
• 5854-78-4(O-tert-Butylthreoninetert-butyl ester)
• 4378-13-6(H-Thr(tBu)-OH)
• 3373-59-9((2S,3R)-methyl 2-amino-3-hydroxybutanoate)
• 201274-81-9(H-D-Thr(tbu)-OH)
• 17012-42-9((2S,3R)-3-Acetoxy-2-aminobutanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)